Conduit Pharmaceuticals Inc (NASDAQ:CDT) currently has a daily average trading volume of 51.16M but it saw 21117445 shares traded in last market. With a market cap of 10.19M USD, the company’s current market price of $0.09 came falling about -7.61 while comparing to the previous closing price of $0.09. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.09 and as low as $0.05. In the recent trading on the day, stock has struck highest price mark of $0.0802 while lowest mark touched by it was $0.0906.
Taking a look at 20-day trading activity of Conduit Pharmaceuticals Inc (CDT) gives us an average price of $0.0765, while its current price level is -97.92% below from 52-week high level whereas it is 66.67% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.0882 while that of 200 days or SMA-200 reads an average of $0.9741. A closer look into the stock’s movement over the week reveals that its volatility is standing at 41.32% during that period while stretching the period over a month that decreases to 24.13%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 50.27 which implies that the stock is in neutral territory.
Over the week, CDT’s stock price is moving -9.57% down while it is 3.66% when we observe its performance for the past one month. Year-to-date it is 23.91% up and over the past year, the stock is showing a downside performance of -97.92%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Conduit Pharmaceuticals Inc’s total number of outstanding shares is 96.00M with 49.12% of that held by the insiders while 4.06% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -89.65%. Stock’s beta reads 2.21. Its return on asset (ROA) is -181.68% on average.
